文献速递血管炎

巨细胞动脉炎患者死亡风险的系统综述与荟萃分析

Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2016-08-25

该系统综述与荟萃分析检索MEDLINE、EMBASE和Cochrane数据库至2015年6月18日,纳入19项观察性研究(其中17项进入荟萃分析),比较巨细胞动脉炎(GCA)患者与一般人群的死亡风险。结果显示,基于人群来源的GCA患者死亡率未增加(MR=1.03,95%CI:0.96-1.10),而医院来源的患者死亡率增加(MR=1.61,95%CI:1.19-2.19);性别间无差异,两项研究提示诊断后早期死亡风险可能增加。

要点

  • 基于人群的GCA患者长期死亡率与一般人群无显著差异(MR=1.03)。
  • 医院来源的GCA患者死亡风险显著增加(MR=1.61)。
  • 诊断后早期死亡风险可能升高,需关注早期管理。

核心结论

  • 在人群水平上,GCA患者长期死亡率未增加,但医院来源患者及诊断后早期死亡风险可能增加。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane数据库至2015年6月18日,纳入19项观察性研究,其中17项进入荟萃分析。

主要发现

  • 基于人群来源的GCA患者死亡率比值比为1.03(95%CI:0.96-1.10),无显著增加。
  • 医院来源的GCA患者死亡率比值比为1.61(95%CI:1.19-2.19),显著增加。
  • 死亡率比值比无性别差异,两项研究提示诊断后早期死亡风险增加。

关键数值与推荐

  • 纳入标准为观察性死亡研究且与一般人群比较,排除仅摘要发表的研究,质量采用Newcastle-Ottawa量表评估。
  • 采用随机效应模型,逆方差法计算死亡率比值比(MR)。

临床怎么用

  • 对医院来源的GCA患者应警惕死亡风险增加,尤其在诊断后早期加强监测与管理。
  • 基于人群的GCA患者长期死亡风险与一般人群相当,可据此进行风险沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies of mortality associated with GCA have shown conflicting results. We conducted a systematic review and meta-analysis to determine the mortality risk in GCA patients compared to the general population. METHODS: We searched for published studies indexed in MEDLINE and EMBASE and the Cochrane database from inception to June 18, 2015 using the terms "giant cell arteritis" and "temporal arteritis" combined with the terms for death, mortality, and survival. A manual search of citations from retrieved articles was also performed. The inclusion criteria were as follows: (1) observational studies of mortality in GCA and (2) comparison of mortality to the general population. Studies published only in abstract form were excluded. Study eligibility and quality (Newcastle-Ottawa scale) were independently assessed by at least two investigators. Random effects meta-analysis of the mortality ratio (MR) was performed by the inverse variance method. RESULTS: Out of 435 potentially relevant articles, 64 studies were reviewed, 19 studies were included in the review and 17 studies were included in the meta-analysis. Mortality was not increased in GCA patients ascertained from a population base (MR = 1.03, 95% CI: 0.96-1.10), but was increased in patients ascertained from a hospital setting (MR = 1.61, 95% CI: 1.19-2.19). There was no difference in MR by gender, and two studies provided evidence that mortality was increased in the early years following diagnosis. CONCLUSION: At a population level, long-term mortality is not increased in GCA. However, mortality risk may be increased in some patients, and may vary over time.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Hill CL, Black RJ, Nossent JC, et al. Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2016. PMID: 28040246. doi:10.1016/j.semarthrit.2016.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。